Chugai Pharmaceutical Co. (CHGCY)
(Delayed Data from OTC)
$23.76 USD
-0.61 (-2.50%)
Updated Oct 2, 2024 03:59 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.56 | 9.99 |
Current Quarter Estimate | NA | 0.26 | 63.00 |
Year Ago Quarter Estimate | 0.16 | -0.05 | 52.25 |
Next Quarter Estimate | NA | -1.84 | 66.00 |
Next Year Estimate | 0.76 | 12.89 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 9.86 | 20.10 | 15.67 |
Next Year | -2.56 | 16.80 | 11.34 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 33.85 | -2.09 |
Price/Book (MRQ) | 6.95 | 1.51 |
Price/Cash Flow (MRFY) | 27.55 | 8.65 |
Dividend Yield | 0.78% | 0.00% |
Net Profit Margin (TTM) | 32.68% | -56.43% |
Return on Equity (TTM) | 21.45% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.